Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CrossFirst Bankshares | CFB | Nov 15, 2024 | 17.13 | -0.81 |
CrowdStrike A | CRWD | Nov 15, 2024 | 336.75 | -2.21 |
Crown Castle | CCI | Nov 15, 2024 | 103.80 | +0.86 |
Crown Crafts | CRWS | Nov 15, 2024 | 4.54 | -0.11 |
Crown ElectroKinetics | CRKN | Nov 15, 2024 | 0.88 | -3.89 |
Crown Holdings | CCK | Nov 15, 2024 | 89.86 | -0.22 |
Crown LNG | CGBS | Nov 15, 2024 | 0.45 | -3.73 |
Cryo-Cell International | CCEL | Nov 15, 2024 | 8.43 | -3.44 |
CryoPort | CYRX | Nov 15, 2024 | 6.99 | -5.28 |
CS Disco | LAW | Nov 15, 2024 | 5.48 | -3.52 |
CSG Systems International | CSGS | Nov 15, 2024 | 54.48 | 0.00 |
CSP | CSPI | Nov 15, 2024 | 12.91 | -0.54 |
CSW Industrials | CSWI | Nov 15, 2024 | 403.98 | -0.93 |
CSX | CSX | Nov 15, 2024 | 35.13 | -1.40 |
CTO Realty Growth | CTO | Nov 15, 2024 | 19.53 | +0.15 |
CTO Realty Growth A Pref | CTO-A | Nov 15, 2024 | 24.16 | +0.52 |
CTS | CTS | Nov 15, 2024 | 53.16 | -1.66 |
CubeSmart | CUBE | Nov 15, 2024 | 48.33 | +0.83 |
Cue Biopharma | CUE | Nov 15, 2024 | 1.25 | -17.00 |
Cullen Frost Bankers B Pref | CFR-B | Nov 15, 2024 | 19.75 | -0.05 |
Cullen/Frost Bankers | CFR | Nov 15, 2024 | 139.27 | -0.15 |
Cullinan Therapeutics | CGEM | Nov 15, 2024 | 13.86 | -9.41 |
Cullman Bancorp | CULL | Nov 15, 2024 | 9.71 | 0.00 |
Culp | CULP | Nov 15, 2024 | 5.07 | +0.80 |
Cumberland Pharmaceuticals | CPIX | Nov 15, 2024 | 1.14 | -5.00 |
Cummins | CMI | Nov 15, 2024 | 361.85 | -0.52 |
Cumulus Media A | CMLS | Nov 15, 2024 | 0.71 | -1.39 |
Curbline Properties | CURB | Nov 15, 2024 | 23.75 | 0.00 |
Curevac N.V. | CVAC | Nov 15, 2024 | 2.54 | -4.87 |
CuriosityStream | CURI | Nov 15, 2024 | 1.63 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.